Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders are buying shares of Gossamer Bio, Pacific Health Care Organization, and System1, indicating confidence in these companies. Notable transactions include Gossamer Bio's CEO buying 372,000 shares, Pacific Health Care Organization's CEO buying 6,270 shares, and System1's 10% owner acquiring 8,013 shares.
June 25, 2024 | 12:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Gossamer Bio's President and CEO Faheem Hasnain acquired 372,000 shares at $0.67 each, indicating strong confidence in the company's future. An analyst recently rated the stock as Outperform with a $9 price target.
The significant insider purchase by the CEO and the recent positive analyst rating suggest strong confidence in the company's future, likely boosting investor sentiment and short-term stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Pacific Health Care Organization's CEO and President Tom Kubota bought 6,270 shares at $0.88 each. The company reported a net income of $176,427 for Q2 2023.
The insider purchase by the CEO and the positive earnings report indicate confidence in the company's performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
System1's 10% owner Cee Holdings Trust acquired 8,013 shares at $1.44 each. The company posted upbeat first-quarter results on May 9.
The insider purchase by a significant shareholder and the positive first-quarter results suggest confidence in the company's future, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70